Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Section Content Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail
-

Division of Bone, Reproductive and Urologic Products (DBRUP)

Director: Hylton V. Joffe, M.D., M.M.Sc.
Deputy Director: Audrey Gassman, M.D.

Chiefs, Project Management Staff: Margaret Kober and Jennifer Mercier 

The Division of Bone, Reproductive and Urologic Products (DBRUP) regulates Investigational New Drug Applications (INDs), New Drug Applications (NDAs), and Biologics Licensing Applications (BLAs) for drugs and biologics intended for the prevention and treatment of reproductive and urologic conditions and conditions involving bone metabolism including: 

  • Benign Disorders of the Prostate and Bladder
  • Contraception
  • Gynecologic Disorders
  • Infertility
  • Menopausal Symptoms
  • Osteoporosis
  • Sexual Dysfunction

 

Mailing Address:
Food and Drug Administration
Center for Drug Evaluation and Research
Division of Bone, Reproductive and Urologic Products
5901-B Ammendale Road
Beltsville, MD 20705-1266
Phone: (301) 796-2130
Fax: (301) 796-9897

-
-